Ralf Gerhard

3.4k total citations
78 papers, 2.7k citations indexed

About

Ralf Gerhard is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Ralf Gerhard has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Infectious Diseases, 46 papers in Immunology and 31 papers in Molecular Biology. Recurrent topics in Ralf Gerhard's work include Clostridium difficile and Clostridium perfringens research (59 papers), Toxin Mechanisms and Immunotoxins (40 papers) and Ion channel regulation and function (13 papers). Ralf Gerhard is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (59 papers), Toxin Mechanisms and Immunotoxins (40 papers) and Ion channel regulation and function (13 papers). Ralf Gerhard collaborates with scholars based in Germany, United States and China. Ralf Gerhard's co-authors include Ingo Just, Harald Genth, Helma Tatge, Klaus Aktories, Fred Hofmann, Alexandra Olling, Andreas Pich, Min Dong, Johannes Huelsenbeck and Liang Tao and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ralf Gerhard

78 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Gerhard Germany 32 1.7k 973 970 405 330 78 2.7k
Harald Genth Germany 28 1.0k 0.6× 823 0.8× 967 1.0× 229 0.6× 213 0.6× 63 2.3k
Jörg Selzer Germany 12 1.2k 0.7× 845 0.9× 1.1k 1.1× 179 0.4× 219 0.7× 14 2.5k
C. von Eichel-Streiber Germany 16 1.2k 0.8× 649 0.7× 824 0.8× 212 0.5× 250 0.8× 18 2.1k
France Moreau Canada 26 528 0.3× 373 0.4× 1.3k 1.3× 439 1.1× 312 0.9× 59 2.3k
Andrew C. Keates United States 29 431 0.3× 1.1k 1.1× 736 0.8× 739 1.8× 314 1.0× 37 2.7k
Christine Tkaczyk United States 35 860 0.5× 2.2k 2.2× 1.3k 1.3× 207 0.5× 232 0.7× 66 3.8k
Antje Blumenthal Australia 33 675 0.4× 945 1.0× 1.3k 1.4× 201 0.5× 674 2.0× 81 2.9k
Eiji Umemoto Japan 23 296 0.2× 1.1k 1.2× 1.1k 1.1× 179 0.4× 242 0.7× 47 2.4k
Olga Kovbasnjuk United States 31 728 0.4× 325 0.3× 1.7k 1.8× 470 1.2× 191 0.6× 83 3.6k
Wolfgang Hans Germany 18 291 0.2× 607 0.6× 1.2k 1.2× 359 0.9× 310 0.9× 31 2.6k

Countries citing papers authored by Ralf Gerhard

Since Specialization
Citations

This map shows the geographic impact of Ralf Gerhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Gerhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Gerhard more than expected).

Fields of papers citing papers by Ralf Gerhard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Gerhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Gerhard. The network helps show where Ralf Gerhard may publish in the future.

Co-authorship network of co-authors of Ralf Gerhard

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Gerhard. A scholar is included among the top collaborators of Ralf Gerhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Gerhard. Ralf Gerhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manion, John, Melissa A. Musser, Min Liu, et al.. (2023). C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation. Nature. 622(7983). 611–618. 35 indexed citations
2.
Mangan, Matthew, Karoline Krause, Anne Pankow, et al.. (2022). Transcriptional licensing is required for Pyrin inflammasome activation in human macrophages and bypassed by mutations causing familial Mediterranean fever. PLoS Biology. 20(11). e3001351–e3001351. 9 indexed citations
3.
Tian, Songhai, Xiaozhe Xiong, Ji Zeng, et al.. (2022). Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants. Nature Communications. 13(1). 6786–6786. 21 indexed citations
4.
Gerhard, Ralf, et al.. (2022). TcdB of Clostridioides difficile Mediates RAS-Dependent Necrosis in Epithelial Cells. International Journal of Molecular Sciences. 23(8). 4258–4258. 16 indexed citations
5.
Chen, Peng, Ji Zeng, Zheng Liu, et al.. (2021). Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection. Nature Communications. 12(1). 3748–3748. 51 indexed citations
6.
Hofmann, Julia, Frank Klawonn, Meina Neumann‐Schaal, et al.. (2021). Clostridioides difficile Toxin CDT Induces Cytotoxic Responses in Human Mucosal-Associated Invariant T (MAIT) Cells. Frontiers in Microbiology. 12. 752549–752549. 14 indexed citations
8.
Tian, Songhai, Yang Liu, Hao Wu, et al.. (2020). Genome-Wide CRISPR Screen Identifies Semaphorin 6A and 6B as Receptors for Paeniclostridium sordellii Toxin TcsL. Cell Host & Microbe. 27(5). 782–792.e7. 28 indexed citations
9.
Tao, Liang, Songhai Tian, Jie Zhang, et al.. (2019). Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells. Nature Microbiology. 4(10). 1760–1769. 73 indexed citations
11.
Lorenz, Dorothea, et al.. (2013). Human mast cell line-1 (HMC-1) cells exhibit a membrane capacitance increase when dialysed with high free-Ca2+ and GTPγS containing intracellular solution. European Journal of Pharmacology. 720(1-3). 227–236. 13 indexed citations
12.
Gerhard, Ralf, Helma Tatge, Oliver Dittrich‐Breiholz, et al.. (2011). Down-regulation of interleukin-16 in human mast cells HMC-1 by Clostridium difficile toxins A and B. Naunyn-Schmiedeberg s Archives of Pharmacology. 383(3). 285–295. 9 indexed citations
13.
14.
Backert, Steffen, Brendan Kenny, Ralf Gerhard, Nicole Tegtmeyer, & Sabine Brandt. (2010). PKA-mediated phosphorylation of EPEC-Tir at serine residues 434 and 463. Gut Microbes. 1(2). 94–99. 7 indexed citations
15.
Genth, Harald, et al.. (2006). Cellular stability of Rho‐GTPases glucosylated by Clostridium difficile toxin B. FEBS Letters. 580(14). 3565–3569. 74 indexed citations
16.
Genth, Harald, Martina Schmidt, Ralf Gerhard, Klaus Aktories, & Ingo Just. (2003). Activation of phospholipase D1 by ADP-ribosylated RhoA. Biochemical and Biophysical Research Communications. 302(1). 127–132. 27 indexed citations
17.
Tatge, Helma, et al.. (2003). Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochemical and Biophysical Research Communications. 307(3). 584–588. 51 indexed citations
18.
Gerhard, Ralf, et al.. (2003). The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochemical and Biophysical Research Communications. 300(3). 706–711. 47 indexed citations
19.
Just, Ingo, Fred Hofmann, Harald Genth, & Ralf Gerhard. (2001). Bacterial protein toxins inhibiting low-molecular-mass GTP-binding proteins. International Journal of Medical Microbiology. 291(4). 243–250. 40 indexed citations
20.
Stein, Jürgen M., et al.. (2000). Analysis of Low‐Molecular‐Weight GTP‐Binding Proteins in Two Functionally Different Intestinal Epithelial Cell Lines. Annals of the New York Academy of Sciences. 915(1). 223–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026